Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale
0651.896.616 · rovalta.com · 27/09/2026
Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBODr Charlotte VAN ENDE - Néphrologie et médecine interne générale is a Private company with limited liability incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Namur.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0651.896.616
- Incorporation
- 13/04/2016
- Legal form
- Private company with limited liability
- Registered office
- Rue de Bauw(ML) 25
5020 Namur · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 10 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -5,1 k € | -815% | 717,4 € | +203% | -694,6 € | -102% | 28,4 k € | -80.6% | 146,6 k € |
| EBITDA | -9,2 k € | -2088% | 461,6 € | +121% | -2,2 k € | -108% | 26,9 k € | -81.4% | 144,7 k € |
| Operating result | -13,3 k € | -2212% | -576,5 € | +92.8% | -8 k € | -344% | 3,3 k € | -97.2% | 116,8 k € |
| Net result | -13,3 k € | -170% | 19,1 k € | +322% | -8,6 k € | -855% | 1,1 k € | -98.9% | 101,5 k € |
| Balance sheet | |||||||||
| Equity | 230,4 k € | -5.5% | 243,8 k € | +8.5% | 224,7 k € | -3.7% | 233,3 k € | +0.5% | 232,1 k € |
| Total assets | 231 k € | -8.6% | 252,8 k € | +3.0% | 245,5 k € | -20.3% | 308,2 k € | -25.2% | 412,1 k € |
| Cash | 7,1 k € | -67.6% | 21,9 k € | +119% | 10 k € | -81.7% | 54,6 k € | -31.3% | 79,5 k € |
| Debts | 511,4 € | -94.3% | 9 k € | -56.6% | 20,8 k € | -71.5% | 73,1 k € | -59.4% | 180 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20252 active · 4 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
| Director | since 01/04/2017 | |
CHARLOTTE VAN ENDE | Director | since 01/09/2015 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
| Manager | since 01/04/2017 | |
DAMIEN PIERRARD | Manager | 01/07/2016 → 01/04/2017 |
DAMIEN PIERRARD | Manager | since 01/07/2016 |
CHARLOTTE VAN ENDE | Manager | since 01/09/2015 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/03/2026 | 28/02/2025 | 29/01/2024 | 31/01/2023 | 31/01/2022 | 28/02/2021 |
| General meeting | 26/12/2025 | 26/12/2024 | 29/12/2023 | 30/12/2022 | 31/12/2021 | 25/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 26/12/2025 | 16/03/2026 | French | |
| Micro model | 30/06/2024 | 26/12/2024 | 28/02/2025 | French | |
| Micro model | 30/06/2023 | 29/12/2023 | 29/01/2024 | French | |
| Micro model | 30/06/2022 | 30/12/2022 | 31/01/2023 | French | |
| Micro model | 30/06/2021 | 31/12/2021 | 31/01/2022 | French | |
| Micro model | 30/06/2020 | 25/12/2020 | 28/02/2021 | French | |
| Micro modelCorrection | 30/06/2019 | 20/07/2020 | 11/08/2020 | French | |
| Micro model | 30/06/2019 | 27/12/2019 | 27/12/2019 | French | |
| Abridged model | 30/06/2018 | 28/12/2018 | 07/02/2019 | French | |
| Abridged model | 30/06/2017 | 29/12/2017 | 28/02/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20252 active · 4 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
| Director | since 01/04/2017 | |
CHARLOTTE VAN ENDE | Director | since 01/09/2015 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
| Manager | since 01/04/2017 | |
DAMIEN PIERRARD | Manager | 01/07/2016 → 01/04/2017 |
DAMIEN PIERRARD | Manager | since 01/07/2016 |
CHARLOTTE VAN ENDE | Manager | since 01/09/2015 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-13,3 k €↓
- 2024Annual accounts 202419,1 k €↑
- 2023Annual accounts 2023-8,6 k €↓
- 2022Annual accounts 20221,1 k €↓
- 2021Annual accounts 2021101,5 k €↑
- 2020Annual accounts 202064,3 k €↓
- 2019Annual accounts 201966,2 k €↑
- 2018Annual accounts 201816,2 k €↓
- 2017Annual accounts 201721,5 k €
- 13/04/2016IncorporationPrivate company with limited liability